| TB control commitment, TB awareness and capacity of health systems | Maintaining and enhancing government commitment to engage with the nonstate, private sector and sustain TB control and elimination |
| Planning and retaining the adequate human resources necessary to ensure quality TB control and elimination activities at all levels |
| Surveillance | Establishing targets, implementing quality surveillance and monitoring (including transition patterns with molecular epidemiology) and adequate modelling to evaluate impact |
| Laboratory services | Improving laboratory services for quality microbiology diagnosis and implementation of ongoing transmission and molecular epidemiology studies |
| Prompt and quality TB care for all | Identifying and addressing social- and economical-TB determinants (e.g. housing, nutrition, smoking, etc.) with particular attention to high-risk groups and vulnerable populations to reduce incidence |
| Improving efficiency of services and ensuring financing of services through social protection mechanisms and universal health coverage/free care |
| Improving service deliveries ensuring early diagnosis, efficient treatment and through-care of all types of TB |
| Multidrug-resistant/extensively drug-resistant TB and TB/HIV co-infection | Preventing emerging of further drug resistance and effective treatment of existing multidrug-resistant/extensively drug-resistant TB cases |
| Preventing further spread of HIV infection, effective testing and anti-retroviral treatment through quality implementation of TB/HIV collaborating activities |
| New tools for TB control and elimination | Ensuring preventive treatment of latent TB infection and airborne infection control |
| Promoting innovative research on new diagnostics, drugs and vaccines |
| Targeting adoption of the new tools to accelerate achievement of TB elimination with special attention to children, people infected with HIV and other immunosuppressed individuals (e.g. tumour necrosis factor-α). |
| Ensuring rational use of new drugs for the treatment of TB and latent TB infection |
| Partnership and collaboration with countries | Developing joint planning and monitoring and evaluation, and pan-European collaboration to sustain TB elimination |